Found 200 matching trials
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy PHASE2 No prospective randomized trials have evaluated the most efficacious dose o...
Show More Location
Dartmouth Hitchcock Medical Center
Learn More & Join Trial
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression PHASE2 Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Show More Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia PHASE2 Severe congenital neutropenia (SCN) is a group of primary immunodeficiencie...
Show More Learn More & Join Trial
Busulfan and Cyclophosphamide Followed By ALLO BMT NA This is a treatment guideline to allow routine clinical data to be collecte...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies PHASE1 This is a phase I, prospective clinical trial studying the safety and feasi...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma PHASE2 Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL PHASE2 Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure PHASE2 Prognosis of patients with graft failure is dismal, and re-transplantation ...
Show More Location
Multiple Locations
Learn More & Join Trial
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies PHASE2 This clinical trial studies the use of reduced intensity chemotherapy and r...
Show More Location
Thomas Jefferson University
Learn More & Join Trial